These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11767079)

  • 41. Design and statistical optimization of an effervescent floating drug delivery system of theophylline using response surface methodology.
    Srikanth Meka V; Ee Li C; Sheshala R
    Acta Pharm; 2016 Mar; 66(1):35-51. PubMed ID: 26959542
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Design and characterization of colon-specific drug delivery system containing paracetamol microsponges.
    Jain V; Singh R
    Arch Pharm Res; 2011 May; 34(5):733-40. PubMed ID: 21656358
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Floating hot-melt extruded tablets for gastroretentive controlled drug release system.
    Fukuda M; Peppas NA; McGinity JW
    J Control Release; 2006 Oct; 115(2):121-9. PubMed ID: 16959356
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Eudragit E PO as a complementary material for designing oral drug delivery systems with controlled release properties: comparative evaluation of new interpolyelectrolyte complexes with countercharged eudragit L100 copolymers.
    Moustafine RI; Bukhovets AV; Sitenkov AY; Kemenova VA; Rombaut P; Van den Mooter G
    Mol Pharm; 2013 Jul; 10(7):2630-41. PubMed ID: 23777284
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Engineering polymer blend microparticles: an investigation into the influence of polymer blend distribution and interaction.
    Alhnan MA; Basit AW
    Eur J Pharm Sci; 2011 Jan; 42(1-2):30-6. PubMed ID: 20950685
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A novel electrostatic dry coating process for enteric coating of tablets with Eudragit® L 100-55.
    Qiao M; Zhang L; Ma Y; Zhu J; Xiao W
    Eur J Pharm Biopharm; 2013 Feb; 83(2):293-300. PubMed ID: 23183445
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A novel double-coating approach for improved pH-triggered delivery to the ileo-colonic region of the gastrointestinal tract.
    Liu F; Moreno P; Basit AW
    Eur J Pharm Biopharm; 2010 Feb; 74(2):311-5. PubMed ID: 19932177
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effect of polymer properties on direct compression and drug release from water-insoluble controlled release matrix tablets.
    Grund J; Koerber M; Walther M; Bodmeier R
    Int J Pharm; 2014 Jul; 469(1):94-101. PubMed ID: 24746409
    [TBL] [Abstract][Full Text] [Related]  

  • 49. pH-independent controlled-release microspheres using polyglycerol esters of fatty acids.
    Akiyama Y; Yoshioka M; Horibe H; Hirai S; Kitamori N; Toguchi H
    J Pharm Sci; 1994 Nov; 83(11):1600-7. PubMed ID: 7891282
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Novel mesalamine-loaded beads in tablets for delayed release of drug to the colon.
    Nguyen C; Christensen JM; Ayres JW
    Pharm Dev Technol; 2012; 17(1):73-83. PubMed ID: 20923254
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Permeability and swelling studies on free films containing inulin in combination with different polymethacrylates aimed for colonic drug delivery.
    Akhgari A; Farahmand F; Afrasiabi Garekani H; Sadeghi F; Vandamme TF
    Eur J Pharm Sci; 2006 Jul; 28(4):307-14. PubMed ID: 16713201
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The influence of HPMC concentration on release of theophylline or hydrocortisone from extended release mini-tablets.
    Mohamed FA; Roberts M; Seton L; Ford JL; Levina M; Rajabi-Siahboomi AR
    Drug Dev Ind Pharm; 2013 Aug; 39(8):1167-74. PubMed ID: 22540355
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Crystal growth formation in melt extrudates.
    Bruce C; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
    Int J Pharm; 2007 Aug; 341(1-2):162-72. PubMed ID: 17524578
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Organic solution versus aqueous dispersion of Eudragit RS in preparation of sustained release microparticles of theophylline using spray drying.
    Garekani HA; Moghaddam ZF; Sadeghi F
    Colloids Surf B Biointerfaces; 2013 Aug; 108():374-9. PubMed ID: 23602991
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of the dispersion of Eudragit S100 powder on the properties of cellulose acetate butyrate microspheres containing theophylline made by the emulsion-solvent evaporation method.
    Obeidat WM; Obaidat IM
    J Microencapsul; 2007 May; 24(3):263-73. PubMed ID: 17454437
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Preparation and characterization of a powder containing an oily liquid drug with Eudragit EPO or L100 copolymer.
    Fujii M; Kawakami A; Saito A; Tuchiya H; Koizumi N; Watanabe Y
    Pharm Dev Technol; 2016 Dec; 21(8):1023-1028. PubMed ID: 26376360
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Enhancement of solubility and dissolution of cilostazol by solid dispersion technique.
    Park JH; Choi HK
    Arch Pharm Res; 2015 Jul; 38(7):1336-44. PubMed ID: 25567762
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The influence of thermal treatment on the release behavior of diclofenac sodium from acrylic matrices.
    Azarmi S; Farid D; Azodi-Deylami S; Ghaffari F; Nokhodchi A
    Pharm Dev Technol; 2005; 10(2):233-9. PubMed ID: 15926672
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tailoring of drug delivery of 5-fluorouracil to the colon via a mixed film coated unit system.
    Kumar RV; Sinha VR
    Acta Pharm; 2011 Sep; 61(3):343-51. PubMed ID: 21945913
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vivo drug release from hydrophilic dextran tablets capable of forming polyion complex.
    Miyazaki Y; Tanaka Y; Yakou S; Takayama K
    J Control Release; 2006 Aug; 114(1):47-52. PubMed ID: 16824636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.